BackCarisma Therapeutics Overview

Carisma Therapeutics Total Revenue

Revenue analysis for CARM.

Quarterly Revenue

N/A

As of Sep 2025

Annual Revenue (TTM)

$3.65M
81.98% YoY

Trailing 12 months ending Sep 2025

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading